Xelpros™ (latanoprost ophthalmic emulsion) – New formulation approval
September 14, 2018 - Sun Pharma announced the FDA approval of Xelpros (latanoprost ophthalmic emulsion), for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension.
Download PDF
